China is among the top countries reporting a high number of diagnosed prevalent cases for gastric, breast, and bladder cancers among the 16 major markets
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
Acquisition expands Merck’s growing hematology portfolio
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Subscribe To Our Newsletter & Stay Updated
